Valuation: Thyrocare Technologies Limited

Capitalization 63.92B 706M 595M 543M 518M 962M 995M 6.3B 2.51B 30.79B 2.65B 2.59B 108B P/E ratio 2026 *
40.8x
P/E ratio 2027 * 33.5x
Enterprise value 63.92B 706M 595M 543M 518M 962M 995M 6.3B 2.51B 30.79B 2.65B 2.59B 108B EV / Sales 2026 *
7.77x
EV / Sales 2027 * 6.66x
Free-Float
27.44%
Yield 2026 *
2.34%
Yield 2027 * 2.9%
1 day+0.42%
1 week-0.93%
Current month-3.82%
1 month-14.00%
3 months-18.94%
6 months-12.18%
Current year-9.57%
1 week 393
Extreme 393
416.2
1 month 376.1
Extreme 376.1
483.35
Current year 376.1
Extreme 376.1
507.75
1 year 219.33
Extreme 219.3333
537.97
3 years 138.67
Extreme 138.6667
537.97
5 years 138.67
Extreme 138.6667
537.97
10 years 135.55
Extreme 135.55
537.97
Manager TitleAgeSince
Chief Executive Officer - 2022-05-03
Compliance Officer - 2025-01-30
Director TitleAgeSince
Director/Board Member - 2017-08-11
Director/Board Member 37 2021-08-31
Director/Board Member - 2022-05-03
Change 5d. change 1-year change 3-years change Capi.($)
+0.42%-0.93%+65.77%+147.88% 706M
-2.18%+5.46%+20.87%+385.94% 28.75B
-1.94%-3.72%-26.44%-25.09% 7.58B
-6.09%+1.12%+5.14%+215.47% 5.05B
-2.55%-3.10%+6.63%+43.22% 2.65B
-0.84%+7.84%+27.76%+580.26% 2.62B
+1.50%+1.12%+69.38%-8.89% 2.16B
+0.22%+0.73%-6.52%-64.60% 2.12B
-1.78%-1.78% - - 1.83B
+1.11%+2.97%+44.74%+25.57% 1.82B
Average -1.21%+2.15%+23.04%+144.42% 5.53B
Weighted average by Cap. -2.07%+3.25%+14.59%+254.90%

Financials

2026 *2027 *
Net sales 8.23B 90.83M 76.54M 69.86M 66.68M 124M 128M 811M 323M 3.96B 341M 334M 13.85B 9.59B 106M 89.24M 81.45M 77.74M 144M 149M 946M 376M 4.62B 397M 389M 16.14B
Net income 1.57B 17.31M 14.59M 13.31M 12.71M 23.6M 24.4M 155M 61.5M 756M 64.92M 63.59M 2.64B 1.91B 21.12M 17.8M 16.24M 15.51M 28.79M 29.78M 189M 75.04M 922M 79.21M 77.59M 3.22B
Net Debt - -
Logo Thyrocare Technologies Limited
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.
Employees
1,822
Date Price Change Volume
26-02-13 403.30 +0.42% 6,491
26-02-12 401.60 -0.52% 13,901
26-02-11 403.70 -0.64% 15,399
26-02-10 406.30 -1.10% 7,812
26-02-09 410.80 +0.91% 7,197
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
401.60INR
Average target price
571.67INR
Spread / Average Target
+42.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. THYROCARE Stock